{
  "doc_id": "N2_Seizure_APR23",
  "file_path": "C:\\Users\\SAHARA\\OneDrive\\Desktop\\uni\\gemma\\risk_score\\rag_store\\sop_pdfs\\N2_Seizure_APR23.pdf",
  "pages": [
    {
      "page_num": 1,
      "text": "April 2023 County of Marin EMS N 2\nSEIZURE\nIndications\n• Recurring or continuous generalized seizures with ALOC\n• Status epilepticus (two or more successive seizures without a period of consciousness, or one\nseizure lasting longer than five minutes\n• ALS RMC\n• ETCO2 monitoring\nIf seizing upon EMS arrival If seizure starts after EMS arrival:\n(suspect status epilepticus): • Midazolam\n• Midazolam IM/IN: 5mg (2.5mg in • IV/IO: 1 mg slowly over 20-30 seconds\neach nostril if IN) • MR q3 min until seizure stops or\n• MR x1 in 2 min if still seizing • Max dose: 0.05mg/kg\n• Do not delay Midazolam • IM/IN: 5mg (2.5mg in each nostril if IN)\nadministration for IV or IO insertion • MR x1 in 2 min if still seizing\nSPECIAL CONSIDERATIONS\n• Consider treatable etiologies\n(hypoglycemia, hypoxia, narcotic\noverdose, unusual odor of alcohol,\nsigns of trauma, medic alert tag) prior\nto administering anti-seizure\nMidazolam Weight Based Chart-\nmedications.\nMAXIMUM DOSING for IV/IO\n• Expect and manage excessive oral\nonly\nsecretions, vomiting, and inadequate\ntidal volume.\nKg Lb Dose (0.05mg/kg)\n• Treatment should be based on the\n40-50 88-110 2-2.5mg\nseverity and length of the seizure\nactivity. 51-60 111-132 2.5-3mg\n• Focal seizures without mental status\n61-70 133-154 3-3.5mg\nchanges may not require pre-hospital\n71-80 155-176 3.5-4mg\npharmacological intervention.\n81-90 177-198 4-4.5mg\n• Never administer Midazolam rapid IV/\nIO since cardiac and/or respiratory 91-100 199-220 4.5-5mg\narrest may occur.\n>100 >220 5mg",
      "image_path": null
    }
  ]
}